Search research articles
Contact Us
Filters
Showing results (241-250 of 374) with videos related to
Page
of 38
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2023
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
J Remon, B Besse, S Ponce Aix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2022
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients
J Chen, F Facchinetti, F Braye, et al.
Journal for Immunotherapy of Cancer
|
August 24, 2022
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer
Myrto K Moutafi, Magdalena Molero, Sandra Martinez Morilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 12, 2018
Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping
J Zugazagoitia, I Ramos, J M Trigo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2022
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022
D Araujo, A Greystoke, S Bates, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 19, 2020
Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group
J Remon, E Nadal, M Dómine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2022
Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM)
A Bayle, F Peyraud, L Belcaid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2023
Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study
A Bayle, L Belcaid, M Aldea, et al.
Gaceta Medica De Mexico
|
January 1, 1996
[AIDS in Mexico and the world: a global view]
G Soberón-Acevedo, P Vilar-Puig, J Ramón de la Fuente, et al.
Science (New York, N.Y.)
|
July 23, 2015
POPULATION GENETICS. Genomic evidence for the Pleistocene and recent population history of Native Americans
Maanasa Raghavan, Matthias Steinrücken, Kelley Harris, et al.
Page
of 38
Search research articles
Search
Showing results (241-250 of 374) with videos related to
Sort By:
Page
of 38
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 2, 2023
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
J Remon, B Besse, S Ponce Aix, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 23, 2022
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients
J Chen, F Facchinetti, F Braye, et al.
Journal for Immunotherapy of Cancer
|
August 24, 2022
Spatially resolved proteomic profiling identifies tumor cell CD44 as a biomarker associated with sensitivity to PD-1 axis blockade in advanced non-small-cell lung cancer
Myrto K Moutafi, Magdalena Molero, Sandra Martinez Morilla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 12, 2018
Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping
J Zugazagoitia, I Ramos, J M Trigo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 1, 2022
Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022
D Araujo, A Greystoke, S Bates, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 19, 2020
Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group
J Remon, E Nadal, M Dómine, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 19, 2022
Liquid versus tissue biopsy for detecting actionable alterations according to the ESMO Scale for Clinical Actionability of molecular Targets in patients with advanced cancer: a study from the French National Center for Precision Medicine (PRISM)
A Bayle, F Peyraud, L Belcaid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 28, 2023
Clinical utility of circulating tumor DNA sequencing with a large panel: a National Center for Precision Medicine (PRISM) study
A Bayle, L Belcaid, M Aldea, et al.
Gaceta Medica De Mexico
|
January 1, 1996
[AIDS in Mexico and the world: a global view]
G Soberón-Acevedo, P Vilar-Puig, J Ramón de la Fuente, et al.
Science (New York, N.Y.)
|
July 23, 2015
POPULATION GENETICS. Genomic evidence for the Pleistocene and recent population history of Native Americans
Maanasa Raghavan, Matthias Steinrücken, Kelley Harris, et al.
Page
of 38